|View printer-friendly version|
|February 07, 2001 11:25 a.m.|
|Teva Announces Final Approvals of Nifedipine XL 30mg and Etodolac ER 400mg|
WILL LAUNCH IMMEDIATELY
Jerusalem, Israel, February 7, 2001 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has awarded final approval for Nifedipine XL 30 mg tablets and Etodolac 400 mg tablets and Teva USA will launch both products immediately.